US firm suggests issues with increasing production at its European plant could affect delivery to UK
The US pharmaceutical company Moderna, which produces the newest vaccine to be rolled out in the UK, is struggling to supply promised shots because of issues with increasing production at its European plant, in the latest problem to hit global vaccination plans.
In a statement on Friday, the company suggested supply of the vaccine would be reduced this month, with doses earmarked for the UK, Canada and other countries expected to be affected.